#IOTech

@moaijobs.bsky.social

10 months ago

image

🚀 @GoogleDeepMind’s Gemini 2.5 Pro Preview (I/O Edition) Drops: #1 in Coding & WebDev, Transforming Images into Code & Building Smart Web Apps 🌐

#GeminiAI #AIcoding #IOTech #DeepMind

0 0 0 0

Sophia Wong

@sophiawongyn.bsky.social

1 year ago

Breaking the mold: Unconventional T cells in cancer therapy Unconventional T cells, including invariant natural killer T (iNKT) cells, gamma delta (γδ) T cells, and mucosal-associated invariant T (MAIT) cells, play important roles in both innate and adaptive immunity. These cells respond to tumors rapidly and influence the tumor microenvironment (TME). Recent advances in understanding their biology, as well as the development of novel therapeutic approaches, have underscored their potential in cancer immunotherapy. This commentary will assess these advances and translational possibilities in the field.

Awesome review on unconventional T cells! Breaking the mold in cancer therapy #CancerCell www.cell.com/cancer-cell/...

Also check out @DrGopalIyer recent review on GD on #ESMO #IOTech
A GD Type of Cancel Culture - www.esmoiotech.org/article/S259...

#CellTherapy
#GammaDelta
#NKT

4 0 0 0

Jon Lim, FRCP PhD

@drjonlim.bsky.social

1 year ago

...and more of our amazing #ESMO #IOTECH Editorial Board members:
@drbetofmdphd.bsky.social
@dgfeller.bsky.social
@kevlitchfield.bsky.social
@artkrieg.bsky.social
@bertrandrouty.bsky.social
@charlesswanton.bsky.social
@pamsharmamdphd.bsky.social

🦋 Follow for insights into #CancerImmunology!

0 2 0 0

Jon Lim, FRCP PhD

@drjonlim.bsky.social

1 year ago

📚 In conjunction with #ESMOImmuno24, we had our annual #ESMO #IOTECH Editorial Board meeting today - delighted to see many more academics now here 🦋.

🎯 EiC: @haanenjohn.bsky.social

Section Editors:
@michalbassani.bsky.social (NeoAg/TILs)
@danielathommen.bsky.social (Biomarkers/novel IO targets)...